Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors

被引:311
作者
Müller, OJ
Kaul, F
Weitzman, MD
Pasqualini, R
Arap, W
Kleinschmidt, JA
Trepel, M
机构
[1] Deutsch Krebsforschungszentrum, Forschungsschwerpunkt Angew Tumorvirol, D-69120 Heidelberg, Germany
[2] Univ Freiburg, Med Ctr, Dept Hematol & Oncol, D-79106 Freiburg, Germany
[3] Univ Freiburg, Med Ctr, Inst Mol Med & Cell Res, D-79106 Freiburg, Germany
[4] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92183 USA
[5] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
10.1038/nbt856
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Characterizing the molecular diversity of the cell surface is critical for targeting gene therapy. Cell type-specific binding ligands can be used to target gene therapy vectors. However, targeting systems in which optimum eukaryotic vectors can be selected on the cells of interest are not available. Here, we introduce and validate a random adeno-associated virus (AAV) peptide library in which each virus particle displays a random peptide at the capsid surface. This library was generated in a three-step system that ensures encoding of displayed peptides by the packaged DNA. As proof-of-concept, we screened AAV-libraries on human coronary artery endothelial cells. We observed selection of particular peptide motifs. The selected peptides enhanced transduction in coronary endothelial cells but not in control nonendothelial cells. This vector targeting strategy has advantages over other combinatorial approaches such as phage display because selection occurs within the context of the capsid and may have a broad range of applications in biotechnology and medicine.
引用
收藏
页码:1040 / 1046
页数:7
相关论文
共 46 条
[1]   Steps toward mapping the human vasculature by phage display [J].
Arap, W ;
Kolonin, MG ;
Trepel, M ;
Lahdenranta, J ;
Cardó-Vila, M ;
Giordano, RJ ;
Mintz, PJ ;
Ardelt, PU ;
Yao, VJ ;
Vidal, CI ;
Chen, L ;
Flamm, A ;
Valtanen, H ;
Weavind, LM ;
Hicks, ME ;
Pollock, RE ;
Botz, GH ;
Bucana, CD ;
Koivunen, E ;
Cahill, D ;
Troncoso, P ;
Baggerly, KA ;
Pentz, RD ;
Do, KA ;
Logothetis, CJ ;
Pasqualini, R .
NATURE MEDICINE, 2002, 8 (02) :121-127
[2]   Toward cell-targeting gene therapy vectors: Selection of cell-binding peptides from random peptide-presenting phage libraries [J].
Barry, MA ;
Dower, WJ ;
Johnston, SA .
NATURE MEDICINE, 1996, 2 (03) :299-305
[3]   Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab′γ)2 antibody [J].
Bartlett, JS ;
Kleinschmidt, J ;
Boucher, RC ;
Samulski, RJ .
NATURE BIOTECHNOLOGY, 1999, 17 (02) :181-186
[4]   SYNTHESIS OF ADENO-ASSOCIATED VIRUS STRUCTURAL PROTEINS REQUIRES BOTH ALTERNATIVE MESSENGER-RNA SPLICING AND ALTERNATIVE INITIATIONS FROM A SINGLE TRANSCRIPT [J].
BECERRA, SP ;
KOCZOT, F ;
FABISCH, P ;
ROSE, JA .
JOURNAL OF VIROLOGY, 1988, 62 (08) :2745-2754
[5]   Enhancement of tumor necrosis factor a antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13) [J].
Curnis, F ;
Sacchi, A ;
Borgna, L ;
Magni, F ;
Gasparri, A ;
Corti, A .
NATURE BIOTECHNOLOGY, 2000, 18 (11) :1185-1190
[6]   Adeno-associated virus type 2 protein interactions: Formation of pre-encapsidation complexes [J].
Dubielzig, R ;
King, JA ;
Weger, S ;
Kern, A ;
Kleinschmidt, JA .
JOURNAL OF VIROLOGY, 1999, 73 (11) :8989-8998
[7]   Anti-cancer activity of targeted pro-apoptotic peptides [J].
Ellerby, HM ;
Arap, W ;
Ellerby, LM ;
Kain, R ;
Andrusiak, R ;
Del Rio, G ;
Krajewski, S ;
Lombardo, CR ;
Rao, R ;
Ruoslahti, E ;
Bredesen, DE ;
Pasqualini, R .
NATURE MEDICINE, 1999, 5 (09) :1032-1038
[8]   Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2 [J].
Girod, A ;
Ried, M ;
Wobus, C ;
Lahm, H ;
Leike, K ;
Kleinschmidt, J ;
Deléage, G ;
Hallek, M .
NATURE MEDICINE, 1999, 5 (09) :1052-1056
[9]   Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids [J].
Grifman, M ;
Trepel, M ;
Speece, P ;
Gilbert, LB ;
Arap, W ;
Pasqualini, R ;
Weitzman, MD .
MOLECULAR THERAPY, 2001, 3 (06) :964-975
[10]   Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2 [J].
Grimm, D ;
Kern, A ;
Pawlita, M ;
Ferrari, FK ;
Samulski, RJ ;
Kleinschmidt, JA .
GENE THERAPY, 1999, 6 (07) :1322-1330